Immune promotion of central nervous system remyelination

Progress in Brain Research

Volumn 103, Issue C, 1994, Pages 343-355

  Rodriguez, Moses ^a   Miller, David J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; MULTIPLE SCLEROSIS; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; ULTRASTRUCTURE;

EID: 0028566459     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)61148-6     Document Type: Article

References (78)

1. Arenella, L.S., Herndon, R.M., Mature oligodendrocytes. Division following experimental demyelination in adult animals. Arch. Neurol. 41 (1984), 1162–1165.
2. Armstrong, R.C., Dorn, H.H., Kufta, C.V., Friedman, E., Dubois Dalcq, M.E., Pre-oligodendrocytes from adult human CNS. J. Neurosci. 12 (1992), 1538–1547.
3. Bansal, R., Gard, A.L., Pfeiffer, S.E., Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid. J. Neurosci. Res. 21 (1988), 260–267.
4. Barnes, D., Munro, P.M., Youl, B.D., Prineas, J.W., McDonald, W.I., The longstanding MS lesion. A quantitative MRI and electron microscopic study. Brain 114 (1991), 1271–1280.
5. Benjamins, J.A., Dyer, C.A., Glycolipids and transmembrane signaling in oligodendroglia. Ann. N.Y. Acad. Sci. 605 (1990), 90–100.
6. Blakemore, W.F., Observations on remyelination in the rabbit spinal cord following demyelination induced by lysolecithin. Neuropathol. Appl. Neurobiol. 4 (1978), 47–59.
7. Blakemore, W.F., Eames, R.A., Smith, K.J., McDonald, W.I., Remyelination in the spinal cord of the cat following intraspinal injections of lysolecithin. J. Neurol. Sci. 33 (1977), 31–43.
8. Clark, E.A., Ledbetter, J.A., Amplification of the immune response by agonistic antibodies. Immunol. Today 7 (1986), 267–270.
9. Cohen, J.A., Williams, W.V., Geller, H.M., Greene, M.I., Anti-reovirus receptor antibody accelerates expression of the optic nerve oligodendrocyte developmental program. Proc. Natl. Acad. Sci. USA 88 (1991), 1266–1270.
10. Cook, C., Dalakas, M., Galdi, A., Biondi, D., Porter, H., High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy. Neurology 40 (1990), 212–214.
11. Cook, S.D., Troiano, R., Rohowsky-Kochan, C., Jotkowitz, A., Bielory, L., Mehta, P.D., Oleske, J., Bansil, S., Dowling, P.C., Intravenous gamma globulin in progressive MS. Acta. Neurol. Scand. 86 (1992), 171–175.
12. Dal Canto, M.C., Barbano, R.L., Remyelination during remission in Theiler's virus infection. Am. J. Pathol. 116 (1984), 30–45.
13. Dal Canto, M.C., Lipton, H.L., Primary demyelination in Theiler's virus infection. An ultrastructural study. Lab. Invest. 33 (1975), 626–637.
14. Dal Canto, M.C., Lipton, H.L., Multiple sclerosis. Animal model: Theiler's virus infection in mice. Am. J. Pathol. 88 (1977), 497–500.
15. Dal Canto, M.C., Lipton, H.L., Recurrent demyelination in chronic central nervous system infection produced by Theiler's murine encephalomyelitis virus. J. Neurol. Sci. 42 (1979), 391–405.
16. Diaz, M., Bornstein, M.B., Raine, C.S., Disorganization of myelinogenesis in tissue culture by anti-CNS antiserum. Brain Res. 154 (1978), 231–239.
17. Dobi, S., Lewkey, B., Role of secretogogue immunoglobulins in gastric acid secretion. Acta. Physiol. Acad. Sci. Hungary 69 (1982), 9–25.
18. Dwyer, J.M., Manipulating the immune system with immune globulin. N. Engl. J. Med. 326 (1992), 107–116.
19. Dyck, P.J., Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy and in neuropathy associated with IgM monoclonal gammopathy of unknown significance. Neurology 40 (1990), 327–328.
20. Farrell, M.A., Kaufmann, J.C., Gilbert, J.J., Noseworthy, J.H., Armstrong, H.A., Ebers, G.C., Oligoclonal bands in multiple sclerosis: clinical-pathologic correlation. Neurology 35 (1985), 212–218.
21. Franklin, R.J., Crang, A.J., Blakemore, W.F., Transplanted type-1 astrocytes facilitate repair of demyelinating lesions by host oligodendrocytes in adult rat spinal cord. J. Neurocytol. 20 (1991), 420–430.
22. Fukue, U., Uchimura, H., Mitsuhasthi, T., Okano, S., Kanaji, U., Takaku, F., Thyroglobulin release-stimulating activity in immunoglobulin G from patients with Graves' disease studied by human thyroid cells in vitro. J. Clin. Endocrinol. Metab. 64 (1987), 261–265.
23. Ghatak, N.R., Hirano, A., Doron, Y., Zimmerman, H.M., Remyelination in multiple sclerosis with peripheral type myelin. Arch. Neurol. 29 (1973), 262–267.
24. Ghatak, N.R., Leshner, R.T., Price, A.C., Felton, W.L. III, Remyelination in the human central nervous system. J. Neuropathol. Exp. Neurol. 48 (1989), 507–518.
25. Hart, I.K., Richardson, W.D., Bolsover, S.R., Raff, M.C., PDGF and intracellular signaling in the timing of oligodendrocyte differentiation. J. Cell Biol. 109 (1989), 3411–3417.
26. Hirsch, R., Eckhaus, M., Auchincloss, H., Sachs, D.H., Bluestone, J.A., Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses. J. Immunol. 140 (1988), 3766–3772.
27. Hirsch, R., Gress, R.E., Pcuznik, D.H., Eckhau, S.M., Bluestone, J.A., Effects of in vivo administration of anti CD3 monoclonal antibody on T cell function in mice. II. In vivo activities of T cells. J. Immunol. 142 (1989), 737–743.
28. Itoyama, Y., Webster, H.D., Richardson, E.P. Jr., Trapp, B.D., Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions. Ann. Neurol. 14 (1983), 339–346.
29. Keilhauer, G., Meier, D.H., Kuhlmann-Krieg, S., Nieke, J., Schachner, M., Astrocytes support incomplete differentiation of an oligodendrocyte precursor cell. EMBO J. 4 (1985), 2499–2504.
30. Kleuweg, R.P., Van der Meche, F.G.A., Meulstee, J., Treatment of Guillain-Barré syndrome with high dose gammaglobulin. Neurology 38 (1988), 1639–1641.
31. Lang, W., Rodriguez, M., Lennon, V.A., Lampert, P.W., Demyelination and remyelination in murine viral encephalomyelitis. Ann. N.Y. Acad. Sci. 436 (1984), 98–102.
32. Lehrer, G.M., Maker, S., Silides, D.J., Weiss, C., Bornstein, M.B., Stimulation of myelin lipids synthesis in vitro by white matter antiserum in the absence of complement. Brain Res. 172 (1979), 557–560.
33. Lehrich, J.R., Arnason, B.G., Hochberg, F.H., Demyelinative myelopathy in mice induced by the DA virus. J. Neurol. Sci. 29 (1976), 149–160.
34. Link, H., Baig, S., Jiang, Y.P., Olsson, O., Hojeberg, B., Kostulas, V., Olsson, T., B cells and antibodies in MS. Res. Immunol. 140 (1989), 219–226.
35. Ludwin, S.K., Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. Lab. Invest. 39 (1978), 597–612.
36. Ludwin, S.K., An autoradiographic study of cellular proliferation in remyelination of the central nervous system. Am. J. Pathol. 95 (1979), 683–696.
37. Ludwin, S.K., Chronic demyelination inhibits remyelination in the central nervous system. An analysis of contributing factors. Lab. Invest. 43 (1980), 382–387.
38. Ludwin, S.K., Proliferation of mature oligodendrocytes after trauma to the central nervous system. Nature (Lond.) 308 (1984), 274–275.
39. Ludwin, S.K., Reaction of oligodendrocytes and astrocytes to trauma and implantation. A combined autoradiographic and immunohistochemical study. Lab. Invest. 52 (1985), 20–30.
40. Ludwin, S.K., Remyelination in demyelinating diseases of the central nervous system. Crit. Rev. Neurobiol. 3 (1987), 1–28.
41. Ludwin, S.K., Remyelination in the central nervous system and the peripheral nervous system. Waxman, S.G., (eds.) Functional Recovery in Neurological Disease. Advances in Neurology, 47, 1988, Raven Press, New York, 215–254.
42. Ludwin, S.K., Evolving concepts and issues in remyelination. Dev. Neurosci. 11 (1989), 140–148.
43. Ludwin, S.K., Bakker, D.A., Can oligodendrocytes attached to myelin proliferate?. J. Neurosci. 8 (1988), 1239–1244.
44. Ludwin, S.K., Johnson, E.S., Evidence for a ‘dyingback’ gliopathy in demyelinating disease. Ann. Neurol. 9 (1981), 301–305.
45. McKinnon, R.D., Matsui, T., Dubois Dalcq, M., Aaronson, S.A., FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5 (1990), 603–614.
46. McKinnon, R.D., Matsui, T., Aranda, M., Dubois Dalcq, M., A role for fibroblast growth factor in oligodendrocyte development. Ann. N.Y. Acad. Sci. 638 (1991), 378–386.
47. Miike, T., Taku, K., Tamura, T., Ohta, J., Ozaki, M., Yamamoto, C., Sakai, T., Antoku, Y., Yadomi, C., Clinical improvement of adrenoleukodystrophy following intravenous gammaglobulin therapy. Brain Dev. 11 (1989), 134–137.
48. Ohta, Y., Tamura, S., Tezuka, E., Sugawara, M., Imai, S., Tanaka, H., Autoimmune MRL/LPR mice sera contain IgG with interleukin 3-like activity. J. Immunol. 140 (1988), 520–525.
49. Patick, A.K., Thiemann, R.L., Brien, P.C.O., Rodriguez, M., Persistence of Theiler's virus infection following promotion of central nervous system remyelination. J. Neuropathol. Exp. Neurol. 50 (1991), 523–537.
50. Prayoonwiwat, N., Rodriguez, M., The potential for oligodendrocyte proliferation during demyelinating disease. J. Neuropathol. Exp. Neurol. 52 (1993), 55–63.
51. Prineas, J.W., Wright, R.G., Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest. 38 (1978), 409–421.
52. Prineas, J.W., Kwon, E.E., Goldenberg, P.Z., Ilyas, A.A., Quarles, R.H., Benjamins, J.A., Sprinkle, T.J., Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions. Lab. Invest. 61 (1989), 489–503.
53. Prineas, J.W., Kwon, E.E., Goldenberg, P.Z., Cho, E.S., Sharer, L.R., Interaction of astrocytes and newly formed oligodendrocytes in resolving multiple sclerosis lesions. Lab. Invest. 63 (1990), 624–636.
54. Prineas, J.W., Barnard, R.O., Kwon, E.E., Sharer, L.R., Cho, E.S., Multiple sclerosis: remyelination of nascent lesions. Ann. Neurol. 33 (1993), 137–151.
55. Raff, M.C., Ffrench-Constant, C., Miller, R.H., Glial cells in the rat optic nerve and some thoughts on remyelination in the mammalian CNS. J. Exp. Biol. 132 (1987), 35–41.
56. Raine, C.S., Traugott, U., Chronic relapsing experimental autoimmune encephalomyelitis. Ultrastructure of the central nervous system of animals treated with combinations of myelin components. Lab. Invest. 48 (1983), 275–284.
57. Raine, C.S., Scheinberg, L., Waltz, J.M., Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. Lab. Invest. 45 (1981), 534–546.
58. Raine, C.S., Hintzen, R., Traugott, U., Moore, G.R., Oligodendrocyte proliferation and enhanced CNS remyelination after therapeutic manipulation of chronic relapsing EAE. Ann. N.Y. Acad. Sci. 540 (1988), 712–714.
59. Raine, C.S., Moore, G.R., Hintzen, R., Traugott, U., Induction of oligodendrocyte proliferation and remyelination after chronic demyelination. Relevance to multiple sclerosis. Lab. Invest. 59 (1988), 467–476.
60. Rodriguez, M., Virus-induced demyelination in mice: ‘dying back’ of oligodendrocytes. Mayo Clin. Proc. 60 (1985), 433–438.
61. Rodriguez, M., Multiple sclerosis: basic concepts and hypothesis. Mayo Clin. Proc. 64 (1989), 570–576.
62. Rodriguez, M., Immunoglobulins stimulate central nervous system remyelination: electron microscopic and morphometric analysis of proliferating cells. Lab. Invest. 64 (1991), 358–370.
63. Rodriguez, M., Lennon, V.A., Immunoglobulins promote remyelination in the central nervous system. Ann. Neurol. 27 (1990), 12–17.
64. Rodriguez, M., Lindsley, M.D., Immunosuppression promotes CNS remyelination in chronic virus-induced demyelinating disease. Neurology 42 (1992), 348–357.
65. Rodriguez, M., Scheithauer, B., The ultrastructure of multiple sclerosis. Ultrastruct. Pathol. 18 (1994), 3–13.
66. Rodriguez, M., Oleszak, E., Leibowitz, J., Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. Crit. Rev. Immunol. 7 (1987), 325–365.
67. Rodriguez, M., Lennon, V.A., Benveniste, E.N., Merrill, J.E., Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. J. Neuropathol. Exp. Neurol. 46 (1987), 84–95.
68. Rodriguez, M., Scheithauer, B.W., Forbes, G., Kelly, P.J., Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin. Proc. 68 (1993), 627–636.
69. Rodriguez, M., Prayoonwiwat, N., Howe, C., Sandborn, K., Proteolipid protein gene expression in demyelination and remyelination of the central nervous system: a model for multiple sclerosis. J. Neuropathol. Exp. Neurol. 53 (1994), 136–143.
70. Schuller, E., Govaerts, A., First results of immunotherapy with immunoglobulin G in multiple sclerosis patients. Eur. Neurol. 22 (1983), 205–212.
71. Soukop, W., Tschabitscher, H., Gammaglobulintherapie bei multipler sklerose (MS). Wien. Med. Wochenschr. 136 (1986), 477–480.
72. Traugott, U., Stone, S.H., Raine, C.S., Chronic relapsing experimental autoimmune encephalomyelitis. Treatment with combinations of myelin components promotes clinical and structural recovery. J. Neurol. Sci. 56 (1982), 65–73.
73. Van Doorn, P.A., Brand, A., Strengers, P.F.W., Meulstee, J., Vermeulen, M., High dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind placebo-controlled, crossover study. Neurology 40 (1990), 209–212.
74. van Engelen, E.G., Hommes, O.R., Pinckers, A., Cruysberg, J.R., Barkhof, F., Rodriguez, M., Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis. Ann. Neurol. 32 (1992), 834–835.
75. Warren, K.G., Catz, I., Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue. J. Neurol. Sci. 115 (1993), 169–176.
76. Wolswijk, G., Noble, M., Cooperation between PDGF and FGF converts slowly dividing O-2A adult progenitor cells to rapidly dividing cells with characteristics of O-2A perinatal progenitor cells. J. Cell Biol. 118 (1992), 889–900.
77. Yajima, K., Suzuki, K., Demyelination and remyelination in the rat central nervous system following ethidium bromide injection. Lab. Invest. 41 (1979), 385–392.
78. Yong, V.W., Sekiguchi, S., Kim, M.W., Kim, S.U., Phorbol ester enhances morphological differentiation of oligodendrocytes in cultures. J. Neurosci. Res. 19 (1988), 187–194.